©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan
FDA-Approved AI Patch! VitalSigns Seeks $4 Million to Ignite a Global Cardiac-Monitoring Revolution
How can we predict heart conditions before they become critical? VitalSigns Corp, a Taiwan-based startup, is working towards an answer. By integrating ECG, vital signs, and AI-driven analytics into a seamless wearable solution, the company is offering a new way for healthcare professionals to monitor patients' heart health proactively. This system allows for continuous cardiac monitoring, potentially preventing life-threatening events like strokes and heart attacks.
The journey of VitalSigns Corp began not just as a business idea, but as a shared vision among Rich Lee (CEO), Leon Chuang (VP of Engineering), and JL Huang (CTO). Their story began in university, where they first collaborated on tech projects that combined innovation and healthcare. Their collaboration led to the creation of a startup focused on providing an affordable and effective solution for continuous heart monitoring.
“We were working on various tech projects together, but we knew we wanted to solve a real-world healthcare issue,” says JL Huang, CTO. “Our shared vision was to create a solution that could monitor heart health more effectively, beyond just detecting symptoms. We wanted a product that would empower doctors and patients to catch heart issues early, before they became emergencies.”
Initially, the startup was envisioned as an IC design company. The goal was to create a device that could measure heart signals for diagnosis, using AI to analyze and predict potential issues. But early challenges, including skepticism from investors and limited resources, pushed the team to pivot. A breakthrough moment came when they received an investment of 1 million USD, allowing them to transition towards developing a wearable medical solution focused on cardiac care.
VitalSigns' technology was born from this shared vision. Their System-in-a-Patch (SIP™) solution integrates ECG monitoring, vital sign tracking, and cloud analytics, offering healthcare professionals a comprehensive tool for continuous, remote patient monitoring. By providing long-term monitoring, their system helps detect issues such as arrhythmia or heart failure well before they lead to critical situations.
A Low-Cost, High-Accuracy Solution
VitalSigns stands out for its combination of high accuracy and affordability. While many current cardiac monitoring systems are expensive or require frequent hospital visits, their SIP™ solution is designed to be both accessible and cost-effective. This approach makes it possible for more people to access vital health data without significant financial barriers.
“The goal was to make the technology as affordable as possible,” says Rich Lee, CEO. “Heart disease is a major issue worldwide, and we wanted to ensure that our solution could be used by a wide range of patients and healthcare providers.”
The patch, which is small and rechargeable, seamlessly collects and transmits ECG and other vital data to the cloud for real-time monitoring. By constantly analyzing this data, the platform provides early warnings and actionable insights that allow healthcare providers to make informed decisions about their patients’ care.
“We want to give doctors the ability to monitor their patients 24/7,” says Leon Chuang, VP of Engineering. “With continuous data streaming, they can make decisions faster and more accurately, without having to wait for a traditional appointment.”
The healthcare industry is witnessing a growing trend towards wearable technology, particularly in cardiac care. This global shift towards personalized and remote patient monitoring aligns perfectly with VitalSigns’ approach. The demand for continuous health data has surged, especially after the COVID-19 pandemic, which accelerated the adoption of telemedicine and remote monitoring solutions.
VitalSigns is stepping into this evolving landscape by offering a solution that not only provides real-time monitoring but also empowers both doctors and patients to stay proactive about heart health. The ability to track cardiac conditions continuously without the need for frequent hospital visits is transforming how healthcare providers and patients manage heart disease.
VitalSigns Gains FDA Approval, Boosting Trust and Expanding Market Reach
VitalSigns has successfully secured FDA and EFDA approvals, reinforcing the credibility and regulatory compliance of its product. These approvals validate the technology for use in major healthcare markets, demonstrating the company's dedication to quality and safety. As a result, VitalSigns is gaining trust from medical institutions and expanding its reach.
In Taiwan, VitalSigns is already working with top medical institutions like Taipei Veterans General Hospital and National Taiwan University Hospital. These partnerships ensure the product is tested in real-world medical environments, integrating smoothly into existing healthcare systems. The product has proven to be a valuable tool for long-term monitoring, helping doctors detect issues early, which may not be visible during a single hospital visit.
“We are making it possible for patients to monitor their heart health from home, without needing to schedule frequent visits to the hospital,” explains JL Huang. “This makes life easier for both patients and doctors.”
Expanding Reach: Aiming for Key Global Healthcare Markets
Looking beyond Taiwan, VitalSigns is focused on expanding its international footprint. The company is preparing for a Series A funding round to raise $4 million, which will be used to scale their operations globally. Their goal is to target major markets like the U.S. and parts of Europe and Asia, providing their advanced cardiac monitoring solution to a larger patient base.
With a current team of 24 employees, VitalSigns is positioned for growth. The company aims to create a more comprehensive health monitoring platform that not only tracks heart health but also addresses other chronic conditions such as diabetes and hypertension, all in one seamless wearable device.
“We are ready to scale and bring our technology to more patients worldwide,” says Rich Lee. “The support we’ve received has been invaluable, and we’re excited about the future.”
One of the standout features of VitalSigns’ solution is the integration of AI-driven analytics. The company’s ECG patch continuously collects data and transmits it to the cloud, where it is processed using advanced algorithms to identify abnormalities such as arrhythmia or irregular heartbeats. The AI system analyzes this data alongside other health metrics like blood pressure and heart rate variability, offering doctors actionable insights for more accurate decision-making.
This integration of AI and real-time data makes VitalSigns’ product unique in the crowded space of wearable health technology. The system not only provides early warnings but also allows for remote adjustments, enabling doctors to intervene before critical situations arise.
Empowering Patients to Take Control of Their Heart Health
At the heart of VitalSigns’ mission is patient empowerment. By providing individuals with the tools to monitor their own health, the company is helping people take more control over their well-being. The app and wearable system make it easy for patients to stay proactive and potentially prevent emergencies by identifying issues early.
“We want to give people the peace of mind to know they’re actively managing their heart health,” says Leon Chuang. “Our system isn’t just for doctors; it’s a tool for patients to be more engaged in their own care.”
With their product, VitalSigns is at the forefront of cardiac healthcare. The team is working on expanding their capabilities to support other chronic care management solutions. The future of the company is exciting, with plans for international expansion and continuous product improvement to better serve healthcare providers and patients around the world.
“We’ve only scratched the surface of what this technology can do,” says Leon Chuang. “We are constantly evolving to make our platform even more capable and accessible.”
©2026 Business Next Media Corp. All Rights Reserved. No.102, Guangfu S. Rd., Da'an Dist., Taipei City 106, Taiwan